Vonafexor, also known as EYP001, is a farnesoid X receptor agonist.
For research use only. We do not sell to patients.
Name | Vonafexor |
---|---|
Iupac Chemical Name | 4-chloro-5-[4-(2,6-dichlorobenzene-1- sulfonyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid |
Synonyms | Vonafexor; EYP001; EYP-001; EYP 001; |
Molecular Formula | C19H15Cl3N2O5S |
Molecular Weight | 489.748 |
Smile | O=C(C(O1)=CC2=C1C=CC(N3CCN(S(=O)(C4=C(Cl)C=CC=C4Cl)=O)CC3)=C2Cl)O |
InChiKey | XLGQSYUNOIJBNR-UHFFFAOYSA-N |
InChi | InChI=1S/C19H15Cl3N2O5S/c20-12-2-1-3-13(21)18(12)30(27,28)24-8-6-23(7-9-24)14-4-5-15-11(17(14)22)10-16(29-15)19(25)26/h1-5,10H,6-9H2,(H,25,26) |
CAS Number | 1192171-69-9 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% Min. |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |
Orrico M, Ronchey S, Setacci C, et al. The "Destino-guided BEVAR" to Catheterize Downward Branches from a Femoral Access: Technical Note and Case Report. Ann Vasc Surg. 2019;57:266-271. doi:10.1016/j.avsg.2018.09.044